Research map: Sarsasapogenin Improves Pathological Phenotypes in MPTP/MPP+-Induced Parkinson’s Disease Models: Synergistic Actions of Neurite Outgrowth, Neurotransmitter Modulation, and Anti-Inflammation

Back to the article

Papers in this map

  1. Protocol for the MPTP mouse model of Parkinson's disease · Vernice R. Jackson-Lewis · 2007 · 1139 citations · Cited by this paper
  2. Neural Correlates of Diagnostic-Relevant Emotional Processing in Schizophrenia and Major Depressive Disorder: Insights from a Replication of fMRI and Self-Report Scales · 2026 · Related
  3. Target identification using drug affinity responsive target stability (DARTS) · Brett Lomenick · 2009 · 1119 citations · Cited by this paper
  4. Long-Term Orchestral String Learning and Event-Related Potentials of Inhibitory Control in Children From Disadvantaged Communities · 2026 · Related
  5. Projections for prevalence of Parkinson’s disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021 · Dongning Su · 2025 · 593 citations · Cited by this paper
  6. Dl-3-n-Butylphthalide Protects Human Brain Microvascular Endothelial Cells Against Ischemic Injury Through Dual Modulation of HIF1α/VEGF-Mediated Angiogenesis and COX2-Mediated Inflammation · 2026 · Related
  7. Axon degeneration in Parkinson's disease · Robert E. Burke · 2012 · 514 citations · Cited by this paper
  8. Cancer Neuroscience of Kinase Inhibitors: On-Target Effects on the Nervous System · 2026 · Related
  9. An update on the diagnosis and treatment of Parkinson disease · Philippe Rizek · 2016 · 458 citations · Cited by this paper
  10. Molecular Mechanisms and Potential Biomarkers of Neuropsychiatric Disorders in Parkinson’s Disease · 2026 · Related
  11. Drug Affinity Responsive Target Stability (DARTS) for Small-Molecule Target Identification · Melody Y. Pai · 2014 · 363 citations · Cited by this paper
  12. Extracellular Vesicle-Mediated Delivery of VEGF and NGF Protects Dopaminergic Neurons in 6-OHDA-Induced Parkinson’s Disease Models · 2026 · Related
  13. CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson's disease · Gregory P. Williams · 2021 · 329 citations · Cited by this paper
  14. Glymphatic-Related Alterations in Major Depressive Disorder and Treatment-Resistant Depression: Imaging Proxies, Mechanistic Links, and Therapeutic Opportunities · 2026 · Related
  15. Identification of Direct Protein Targets of Small Molecules · Brett Lomenick · 2010 · 300 citations · Cited by this paper
  16. Atractylodin Suppresses Fibrotic Scar Formation and Enhances Functional Recovery Following Spinal Cord Injury · 2026 · Related
  17. Retrograde Axonal Degeneration in Parkinson Disease · Patricia A. Tagliaferro · 2016 · 281 citations · Cited by this paper
  18. A Capacitance-Based System for Measuring Licking Behaviour in Rodents With Sub-Second Precision · 2026 · Related
  19. Biology of Hsp47 (Serpin H1), a collagen-specific molecular chaperone · Shinya Ito · 2016 · 271 citations · Cited by this paper
  20. Single-Cell and Integrative Analyses Uncover Therapeutic Potential of RFX1-Mediated Cuproptosis in PitNETs · 2026 · Related
  21. Biomarker of Neuroinflammation in Parkinson’s Disease · Tsai-Wei Liu · 2022 · 260 citations · Cited by this paper
  22. Alpha-Synuclein in Parkinson’s Disease: From Pathogenetic Dysfunction to Potential Clinical Application · Lingjia Xu · 2016 · 232 citations · Cited by this paper
  23. Reassessment of subacute MPTP-treated mice as animal model of Parkinson's disease · Qiu-Shuang Zhang · 2017 · 212 citations · Cited by this paper
  24. Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's disease · Lars Tönges · 2012 · 175 citations · Cited by this paper
  25. Interactome Screening Identifies the ER Luminal Chaperone Hsp47 as a Regulator of the Unfolded Protein Response Transducer IRE1α · Denisse Sepúlveda · 2018 · 174 citations · Cited by this paper
  26. Behavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson's disease · Dirk W. Luchtman · 2009 · 166 citations · Cited by this paper
  27. The potential role of neuroinflammation and transcription factors in Parkinson disease · Prafulla Chandra Tiwari · 2017 · 166 citations · Cited by this paper
  28. Alpha-Synuclein affects neurite morphology, autophagy, vesicle transport and axonal degeneration in CNS neurons · Jan Christoph Koch · 2015 · 148 citations · Cited by this paper
  29. Insight Into the Emerging Role of Striatal Neurotransmitters in the Pathophysiology of Parkinson’s Disease and Huntington’s Disease: A Review · Sumit Jamwal · 2018 · 131 citations · Cited by this paper
  30. Neuropathogenesis-on-chips for neurodegenerative diseases · Sarnai Amartumur · 2024 · 112 citations · Cited by this paper
  31. The Proteasome Inhibition Model of Parkinson’s Disease · Eduard Bentea · 2016 · 111 citations · Cited by this paper
  32. Mechanisms compensating for dopamine loss in early Parkinson disease · Jonathan M. Brotchie · 2009 · 103 citations · Cited by this paper
  33. Chronic and progressive Parkinson's disease MPTP model in adult and aged mice · Ana B. Muñoz‐Manchado · 2015 · 94 citations · Cited by this paper
  34. Is Axonal Degeneration a Key Early Event in Parkinson’s Disease? · Zuzanna Kurowska · 2016 · 61 citations · Cited by this paper
  35. Neurochemical, histological, and behavioral profiling of the acute, sub‐acute, and chronic MPTP mouse model of Parkinsonʼs disease · Matteo Santoro · 2022 · 46 citations · Cited by this paper
  36. Dopaminergic Axons: Key Recitalists in Parkinson’s Disease · Abhishek Kumar Mishra · 2021 · 44 citations · Cited by this paper
  37. Chemistry, Biosynthesis and Pharmacology of Sarsasapogenin: A Potential Natural Steroid Molecule for New Drug Design, Development and Therapy · Nur Hanisah Mustafa · 2022 · 43 citations · Cited by this paper
  38. Sarsasapogenin‐ AA 13 ameliorates Aβ‐induced cognitive deficits via improving neuroglial capacity on Aβ clearance and antiinflammation · Cui Huang · 2017 · 42 citations · Cited by this paper
  39. Identification of Adenylate Kinase 5 as a Protein Target of Ginsenosides in Brain Tissues Using Mass Spectrometry-Based Drug Affinity Responsive Target Stability (DARTS) and Cellular Thermal Shift Assay (CETSA) Techniques · Feiyan Chen · 2022 · 41 citations · Cited by this paper

Source: OpenAlex (CC0)